HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) CME: Take the course for this article: HPV Communication: Review of Existing Research and Recommendations for Pati... Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anhang, R. Articles by Goldie, S. J. Search for Related Content PubMed PubMed Citation Articles by Anhang, R. Articles by Goldie, S. J.

HPV Communication: Review of Existing Research and Recommendations for Patient Education

Ms. Anhang is Research Associate, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA.
Dr. Goodman is Associate Director, Division of Gynecology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Dr. Goldie is Associate Professor, Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA.

The potential for human papillomavirus (HPV) DNA testing in cervical cancer prevention programs has been a topic at the forefront of cervical cancer policy discussions in recent years. To prevent some of the anxiety and psychological distress often experienced on HPV diagnosis and during the period of management, mass patient education must accompany the incorporation of HPV DNA testing into screening protocols. To contribute to a growing body of work that provides an empiric basis for development of effective counseling messages about HPV and HPV testing, this paper highlights women’s most common information gaps and psychosocial concerns and describes the different perspectives offered by women’s usual sources of information about HPV, including the crucial role of the clinical community in creating a shared decision making environment in which screening decisions and results can be discussed.

This article has been cited by other articles:

				E. D. Cox, M. A. Smith, and R. L. Brown Evaluating Deliberation in Pediatric Primary Care Pediatrics, July 1, 2007; 120(1): e68 - e77. [Abstract] [Full Text] [PDF]

				G. W. Bock and B. M. Kwan Encouragement of Patient Self-management and Adherence through Use of a Computerized Tracking System for Cervical and Colon Cancer Screening J Am Board Fam Med, May 1, 2007; 20(3): 316 - 319. [Full Text] [PDF]

				D. Saslow, P. E. Castle, J. T. Cox, D. D. Davey, M. H. Einstein, D. G. Ferris, S. J. Goldie, D. M. Harper, W. Kinney, A.-B. Moscicki, et al. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors CA Cancer J Clin, January 1, 2007; 57(1): 7 - 28. [Abstract] [Full Text] [PDF]

				K. Irwin, D. Montano, D. Kasprzyk, L. Carlin, C. Freeman, R. Barnes, N. Jain, J. Christian, and C. Wolters Cervical Cancer Screening, Abnormal Cytology Management, and Counseling Practices in the United States Obstet. Gynecol., August 1, 2006; 108(2): 397 - 409. [Abstract] [Full Text] [PDF]

				C. Worda, A. Huber, G. Hudelist, C. Schatten, H. Leipold, K. Czerwenka, and W. Eppel Prevalence of Cervical and Intrauterine Human Papillomavirus Infected in the Third Trimester in Asymptomatic Women Reproductive Sciences, September 1, 2005; 12(6): 440 - 444. [Abstract] [PDF]

				D. M. Harper Why Am I Scared of HPV? CA Cancer J Clin, September 1, 2004; 54(5): 245 - 247. [Full Text] [PDF]